Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Interest Expenses (2025)

Mangoceuticals' Interest Expenses history spans 1 years, with the latest figure at $19663.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses changed N/A to $19663.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $103513.0, a N/A change, with the full-year FY2025 number at $103513.0, up 655.57% from a year prior.
  • Interest Expenses hit $19663.0 in Q4 2025 for Mangoceuticals, down from $75850.0 in the prior quarter.
  • Over the last five years, Interest Expenses for MGRX hit a ceiling of $75850.0 in Q3 2025 and a floor of -$13700.0 in Q1 2025.